Korro Bio KRRO
NASDAQ KRRO
$9.59 -0.12 (-1.25%)
As of: Oct 2, 2026 · 10:01 AM EDT

Korro Bio (KRRO) EV to CFO (2019 - 2020)

Updated

Korro Bio's EV to CFO came in at 1433.08 for Q2 2020, up 62.1% from the prior quarter.

Analysis

Korro Bio (KRRO) EV to CFO (2019 - 2020) Analysis & Trends

Over the trailing twelve months to Jun 30, 2020, Korro Bio reported EV to CFO of 1409.72; for FY2019, it was 215.21.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Korro Bio 145.73 Mn -250.91 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 1,433.08
Mar 31, 2020 884.03
Dec 31, 2019 215.21
API Access

Korro Bio EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=KRRO&period=max&api_key=YOUR_API_KEY